Jump Financial LLC Raises Stake in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Jump Financial LLC increased its stake in DENTSPLY SIRONA Inc. by 361.1%, acquiring an additional 200,661 shares, resulting in a total holding of 256,234 shares worth approximately $3.83 million.
• Multiple institutional investors have recently raised their stakes in DENTSPLY SIRONA, with ownership from institutional investors totaling 95.70% of the company's stock.
• DENTSPLY SIRONA's quarterly earnings beat expectations, reporting $0.52 earnings per share, but revenue declined by 4.9% year-over-year.

Jump Financial LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 361.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 256,234 shares of the medical instruments supplier's stock after acquiring an additional 200,661 shares during the quarter. Jump Financial LLC owned about 0.13% of DENTSPLY SIRONA worth $3,828,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $25,000. Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. Brooklyn Investment Group purchased a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $26,000. Caitong International Asset Management Co. Ltd boosted its position in shares of DENTSPLY SIRONA by 8,003.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 2,241 shares during the last quarter. Finally, True Wealth Design LLC boosted its position in shares of DENTSPLY SIRONA by 866.7% during the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after buying an additional 1,950 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY traded down $0.02 during trading on Friday, reaching $14.30. 1,864,538 shares of the stock traded hands, compared to its average volume of 3,832,729. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.48. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a 50-day moving average of $15.15 and a 200-day moving average of $15.32. The stock has a market capitalization of $2.85 billion, a P/E ratio of -3.02, a price-to-earnings-growth ratio of 0.89 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. During the same quarter in the prior year, the firm earned $0.49 EPS. The business's revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is currently -13.50%.

Analyst Ratings Changes

XRAY has been the topic of several analyst reports. Stifel Nicolaus cut their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research report on Friday, August 8th. Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, August 8th. UBS Group reduced their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Barrington Research reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Finally, Wall Street Zen downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.